Form 4: Hims & Hers Health Director, Delos M. Cosgrove, Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Director Delos M. Cosgrove reports acquisition of 9,935 Restricted Stock Units (RSUs) in Hims & Hers Health, Inc.
Summary
- On August 7, 2024, Delos M. Cosgrove, a director of Hims & Hers Health, Inc., acquired 9,935 Restricted Stock Units (RSUs).
- These RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
- The RSUs will vest on the earlier of the date of the 2025 annual meeting of stockholders or June 15, 2025, subject to continuous service.
- Following the transaction, Cosgrove beneficially owns 9,935 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns director interests with company performance.
Future Outlook
The RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025, subject to continuous service.
Industry Context
This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies.
Stakeholder Impact
- The acquisition of RSUs by a director aligns their interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 08/07/2024 | Date of transaction: Acquisition of Restricted Stock Units |
| 08/08/2024 | Date of signature for the Form 4 filing |
| June 15, 2025 | Potential vesting date for RSUs |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.